THU0177 TREATMENT PATTERNS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH A BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUG OR JAK INHIBITOR: A NATION-WIDE STUDY IN KOREA

Min Jung Kim(University of British Columbia), Eun Ha Kang(Seoul National University Bundang Hospital), Yun Jong Lee(Seoul National University), Yeong Wook Song(AbbVie (United States)), Anna Shin(Seoul National University Bundang Hospital), You‐Jung Ha(Seoul National University Bundang Hospital), Seung-Hwan Shin(Seoul National University Bundang Hospital), Eun Bong Lee(Seoul National University Hospital)
Annals of the Rheumatic Diseases
June 1, 2019
10.1136/annrheumdis-2019-eular.2777
Cited by 1

Related Papers

Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
|PLoS Genetics|2011|231
Prevalence of Comorbidity among People with Hypertension: The Korea National Health and Nutrition Examination Survey 2007-2013
|Korean Circulation Journal|2016|92
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
|European Heart Journal|2021|75
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study
|BMJ|2024|55
Weight perception and its association with socio-demographic and health-related factors among Korean adolescents
|BMC Public Health|2015|53